Pentasa 1g Suppositories
Pentasa® 1g Suppositories 1005^|
(mesalazine)
PATIENT INFORMATION LEAFLET
Your medicine is available as the above name but will be referred to as Pentasa throughout the following.
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Pentasa is and what it is used for
2. Before you use Pentasa
3. How to use Pentasa
4. Possible side effects
5. How to store Pentasa
6. Further Information
1. WHAT PENTASA IS AND WHAT IT IS USED FOR
The name of this medicine is Pentasa 1g Suppositories. Each suppository contains mesalazine 1g as the active ingredient. Mesalazine belongs to a group of medicines called salicylates.
Pentasa is used to treat inflammation in the gut caused by conditions such as ulcerative colitis. Sometimes ulcerative colitis only affects the back passage (rectum), this is known as ulcerative proctitis. Pentasa suppositories are used to treat ulcerative proctitis and are intended for rectal use only.
The suppositories release the active ingredient slowly which then acts locally to reduce the inflammation and help relieve or stop the pain.
2. BEFORE YOU USE PENTASA Do Not use Pentasa if you:
- are allergic to mesalazine or any of the other ingredients in Pentasa
- are allergic to any other salicylates e.g. aspirin
- have severe liver or kidney problems
- are under the age of 15 years
Take special care with Pentasa
You should consult your doctor before using these suppositories if:
- you currently have, or have previously had liver or kidney disease
- you are on any medication that may affect kidney function e.g. azathioprine
- you have ever had an allergy to a medication called sulphasalazine
You should make sure that you don't become dehydrated, while you are using this medicine. This can occur after severe or prolonged attacks of vomiting and/or diarrhoea, high fever or heavy sweating.
If this does occur, you should speak to a doctor or pharmacist for advice as soon as possible.
While you are using Pentasa your doctor may occasionally want to check your kidney function.
Using with other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This is especially important if you are taking any of the following :
- Non-steroidal anti-inflammatories (NSAIDS)
- Azathioprine or 6-mercaptopurine
Pregnancy and Breastfeeding
If you are pregnant, are planning to become pregnant or are breastfeeding you should speak to your doctor or pharmacist before taking this medicine.
How to insert the suppository
You should make sure that you empty your bowels before inserting the suppository.
a. Tear along the perforation to remove one suppository blister from a blister strip
b. Put a protector on the finger with which you will insert the suppository
c. Remove the suppository from the blister before insertion. This is done by pushing the suppository through the printed foil
d. Insertion may be made easier if you moisten the suppository with water first
e. Insert the suppository gently and fully into the back passage.
It may help to lie down on one side and raise the other knee
f. Remain still for a few minutes after insertion to help keep the suppository in place. If it comes out within 10 minutes, a new one should be inserted
g. Dispose of the empty blister and used finger protector safely and wash your hands
If you use more Pentasa than you should
If you accidentally use too many suppositories, you should go to your nearest emergency department or contact your doctor immediately.
Take the pack and any remaining suppositories with you.
If you forget to use Pentasa
If you forget to use a dose, use the next dose as soon as you remember, unless it is less than 6 hours until your next dose. Do not use a double dose to make up for the forgotten one.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Pentasa can cause side effects, although not everyone gets them.
Following rectal administration local reactions such as itching, rectal discomfort and urge may occur.
STOP taking Pentasa if you notice:
- itching, skin rashes, swelling of the face, lips or throat, difficulty in breathing, wheeziness or coughing (signs of an allergic reaction).
- skin disorder due to an allergic reaction or infection (Erythema Multiforme or Stevens-Johnson syndrome). Symptoms include severe rash, blisters or red splotches on the skin.
- unexplained bleeding, bruising, skin rashes, fever or sore throat (signs of blood disorder).
- change in colour or amount of urine produced (signs of kidney problems).
If you experience any of the above side effects, you should contact your doctor or go to the nearest hospital immediately.
Common side effects (affecting upto 1 in 100 people) include:
- vomiting
- nausea
- headache
- stomach pain
- diarrhoea
Rare side effects (affecting between 1 in 100 and 1 in 10,000) include:
- tingling or numbness in the hands and feet
- inflammation of the heart or area surrounding the heart
- inflammation of the pancreas
- inflammation of the liver and liver failure
- Lupus erythematosis (an auto-immune disorder affecting the skin)
- kidney failure
If you experience any of the above side effects you should contact your doctor or go to the nearest hospital immediately.
Very rare side effects (affecting less than 1 in 10,000 people) include:
- raised liver enzymes
- hair loss (reversible)
- muscle pain
- joint pain
3. HOW TO USE PENTASA
Always use Pentasa exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The suppository should be inserted into the back passage (rectum) only. It is intended to be left in place for as long as possible and is therefore best inserted before going to sleep.
To treat an attack of proctitis your doctor will usually prescribe one suppository to be used daily for two to four weeks.
To help prevent further attacks it may be used for longer.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.
5. HOW TO STORE PENTASA
Keep out of the sight and reach of children.
Do not store above 25oC.
Store in the original package in order to protect from light.
Do not use after the expiry date marked on the packaging.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer required. These measures will help to protect the environment.
If your suppositories become discoloured or show any other signs of deterioration, consult your doctor or pharmacist who will tell you what to do.
6. FURTHER INFORMATION What Pentasa contains
Each suppository contains 1g mesalazine.
Also contains povidone, magnesium stearate, macrogol 6000 and talc.
What Pentasa looks like and the contents of the pack
Pentasa are oblong, compressed white to light tan, speckled suppositories. They are presented in blister strips of 7 suppositories per strip.
Each carton contains 28 suppositories together with finger protectors for use when inserting the suppository.
Manufacturer and Product Licence holder
Manufactured by Ferring GmbH, Wittland 11, P.O. Box 2145, 24109 Kiel, Germany. Procured from within the EU by Product Licence holder Star Pharmaceuticals Ltd, 5 Sandridge Close, Harrow, Middlesex, HA1 1XD. Repackaged by Servipharm Ltd.
POM
PL 20636/2712
Leaflet revision and issue (Ref) 10.05.16[3] Pentasa is a trademark of Ferring B.V.
Mesalazine® 1g Suppositories 1005^|
PATIENT INFORMATION LEAFLET
Your medicine is available as the above name but will be referred to as Mesalazine throughout the following.
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Mesalazine is and what it is used for
2. Before you use Mesalazine
3. How to use Mesalazine
4. Possible side effects
5. How to store Mesalazine
6. Further Information
1. WHAT MESALAZINE IS AND WHAT IT IS USED FOR
The name of this medicine is Mesalazine 1g Suppositories. Each suppository contains mesalazine 1g as the active ingredient. Mesalazine belongs to a group of medicines called salicylates.
Mesalazine is used to treat inflammation in the gut caused by conditions such as ulcerative colitis. Sometimes ulcerative colitis only affects the back passage (rectum), this is known as ulcerative proctitis. Mesalazine suppositories are used to treat ulcerative proctitis and are intended for rectal use only.
The suppositories release the active ingredient slowly which then acts locally to reduce the inflammation and help relieve or stop the pain.
2. BEFORE YOU USE MESALAZINE Do Not use Mesalazine if you:
- are allergic to mesalazine or any of the other ingredients in Mesalazine
- are allergic to any other salicylates e.g. aspirin
- have severe liver or kidney problems
- are under the age of 15 years
Take special care with Mesalazine
You should consult your doctor before using these suppositories if:
- you currently have, or have previously had liver or kidney disease
- you are on any medication that may affect kidney function e.g. azathioprine
- you have ever had an allergy to a medication called sulphasalazine
You should make sure that you don't become dehydrated, while you are using this medicine. This can occur after severe or prolonged attacks of vomiting and/or diarrhoea, high fever or heavy sweating.
If this does occur, you should speak to a doctor or pharmacist for advice as soon as possible.
While you are using Mesalazine your doctor may occasionally want to check your kidney function.
Using with other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This is especially important if you are taking any of the following :
- Non-steroidal anti-inflammatories (NSAIDS)
- Azathioprine or 6-mercaptopurine
Pregnancy and Breastfeeding
If you are pregnant, are planning to become pregnant or are breastfeeding you should speak to your doctor or pharmacist before taking this medicine.
3. HOW TO USE MESALAZINE
Always use Mesalazine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The suppository should be inserted into the back passage (rectum) only. It is intended to be left in place for as long as possible and is therefore best inserted before going to sleep.
To treat an attack of proctitis your doctor will usually prescribe one suppository to be used daily for two to four weeks.
To help prevent further attacks it may be used for longer.
How to insert the suppository
You should make sure that you empty your bowels before inserting the suppository.
a. Tear along the perforation to remove one suppository blister from a blister strip
b. Put a protector on the finger with which you will insert the suppository
c. Remove the suppository from the blister before insertion. This is done by pushing the suppository through the printed foil
d. Insertion may be made easier if you moisten the suppository with water first
e. Insert the suppository gently and fully into the back passage.
It may help to lie down on one side and raise the other knee
f. Remain still for a few minutes after insertion to help keep the suppository in place. If it comes out within 10 minutes, a new one should be inserted
g. Dispose of the empty blister and used finger protector safely and wash your hands
If you use more Mesalazine than you should
If you accidentally use too many suppositories, you should go to your nearest emergency department or contact your doctor immediately.
Take the pack and any remaining suppositories with you.
If you forget to use Mesalazine
If you forget to use a dose, use the next dose as soon as you remember, unless it is less than 6 hours until your next dose. Do not use a double dose to make up for the forgotten one.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Mesalazine can cause side effects, although not everyone gets them.
Following rectal administration local reactions such as itching, rectal discomfort and urge may occur.
STOP taking Mesalazine if you notice:
- itching, skin rashes, swelling of the face, lips or throat, difficulty in breathing, wheeziness or coughing (signs of an allergic reaction).
- skin disorder due to an allergic reaction or infection (Erythema Multiforme or Stevens-Johnson syndrome). Symptoms include severe rash, blisters or red splotches on the skin.
- unexplained bleeding, bruising, skin rashes, fever or sore throat (signs of blood disorder).
- change in colour or amount of urine produced (signs of kidney problems).
If you experience any of the above side effects, you should contact your doctor or go to the nearest hospital immediately.
Common side effects (affecting upto 1 in 100 people) include:
- vomiting
- nausea
- headache
- stomach pain
- diarrhoea
Rare side effects (affecting between 1 in 100 and 1 in 10,000) include:
- tingling or numbness in the hands and feet
- inflammation of the heart or area surrounding the heart
- inflammation of the pancreas
- inflammation of the liver and liver failure
- Lupus erythematosis (an auto-immune disorder affecting the skin)
- kidney failure
If you experience any of the above side effects you should contact your doctor or go to the nearest hospital immediately.
Very rare side effects (affecting less than 1 in 10,000 people) include:
- raised liver enzymes
- hair loss (reversible)
- muscle pain
- joint pain
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.
5. HOW TO STORE MESALAZINE
Keep out of the sight and reach of children.
Do not store above 25oC.
Store in the original package in order to protect from light.
Do not use after the expiry date marked on the packaging.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer required. These measures will help to protect the environment.
If your suppositories become discoloured or show any other signs of deterioration, consult your doctor or pharmacist who will tell you what to do.
6. FURTHER INFORMATION What Mesalazine contains
Each suppository contains 1g mesalazine.
Also contains povidone, magnesium stearate, macrogol 6000 and talc.
What Mesalazine looks like and the contents of the pack
Mesalazine are oblong, compressed white to light tan, speckled suppositories.
They are presented in blister strips of 7 suppositories per strip.
Each carton contains 28 suppositories together with finger protectors for use when inserting the suppository.
Manufacturer and Product Licence holder
Manufactured by Ferring GmbH, Wittland 11, P.O. Box 2145, 24109 Kiel, Germany. Procured from within the EU by Product Licence holder Star Pharmaceuticals Ltd, 5 Sandridge Close, Harrow, Middlesex, HA1 1XD. Repackaged by Servipharm Ltd.
POM
PL 20636/2712
Leaflet revision and issue (Ref) 10.05.16[3]